Pub Date : 1985-10-01Epub Date: 2004-04-15DOI: 10.1016/0006-2944(85)90112-7
Mendel Tuchman, Robert O. Fisch, Margaret L. Ramnaraine, William Krivit
Seven aromatic metabolites of phenylalanine were determined in plasma of 20 patients with classical phenylketonuria by means of capillary gas chromatography. The results obtained showed good correlation with plasma phenylalanine levels. Plasma aromatic acid levels may prove useful in the diagnosis and management of phenylketonuria, as well as in research of this disorder.
{"title":"Acidic metabolites of phenylalanine in plasma of phenylketonurics","authors":"Mendel Tuchman, Robert O. Fisch, Margaret L. Ramnaraine, William Krivit","doi":"10.1016/0006-2944(85)90112-7","DOIUrl":"10.1016/0006-2944(85)90112-7","url":null,"abstract":"<div><p>Seven aromatic metabolites of phenylalanine were determined in plasma of 20 patients with classical phenylketonuria by means of capillary gas chromatography. The results obtained showed good correlation with plasma phenylalanine levels. Plasma aromatic acid levels may prove useful in the diagnosis and management of phenylketonuria, as well as in research of this disorder.</p></div>","PeriodicalId":8781,"journal":{"name":"Biochemical medicine","volume":"34 2","pages":"Pages 203-206"},"PeriodicalIF":0.0,"publicationDate":"1985-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0006-2944(85)90112-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15195448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1985-10-01Epub Date: 2004-04-15DOI: 10.1016/0006-2944(85)90113-9
J.P. Nagpal , R.K. Wali , R. Singh , S. Farooqui , S. Majumdar , A. Mahmood
The effect of isatin (indole-2,3-dione) on d-glucose uptake has been studied in rat intestine. Isatin at 6 mm concentration significantly inhibited both the sugar uptake and transmural (mucosal to serosal side) transport in the intestine. The suppression of glucose uptake by isatin was irreversible. Similar to the action of various SH-group-reacting agents, isatin inhibited the sugar uptake, presumably by binding to membrane sulfhydryl groups through a covalent linkage. Isatin-induced reduction in glucose uptake was unaffected by pH (between 5.5 and 8.4) and by DTT addition to incubation medium. Inhibition of sugar uptake by isatin and harmaline was additive in nature; this suggested that these compounds interact at different sites on the microvillus membrane surface.
{"title":"Inhibition of d-glucose uptake by isatin in rat intestine: Effect of harmaline and various sulfhydryl reagents","authors":"J.P. Nagpal , R.K. Wali , R. Singh , S. Farooqui , S. Majumdar , A. Mahmood","doi":"10.1016/0006-2944(85)90113-9","DOIUrl":"10.1016/0006-2944(85)90113-9","url":null,"abstract":"<div><p>The effect of isatin (indole-2,3-dione) on <span>d</span>-glucose uptake has been studied in rat intestine. Isatin at 6 m<span>m</span> concentration significantly inhibited both the sugar uptake and transmural (mucosal to serosal side) transport in the intestine. The suppression of glucose uptake by isatin was irreversible. Similar to the action of various SH-group-reacting agents, isatin inhibited the sugar uptake, presumably by binding to membrane sulfhydryl groups through a covalent linkage. Isatin-induced reduction in glucose uptake was unaffected by pH (between 5.5 and 8.4) and by DTT addition to incubation medium. Inhibition of sugar uptake by isatin and harmaline was additive in nature; this suggested that these compounds interact at different sites on the microvillus membrane surface.</p></div>","PeriodicalId":8781,"journal":{"name":"Biochemical medicine","volume":"34 2","pages":"Pages 207-213"},"PeriodicalIF":0.0,"publicationDate":"1985-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0006-2944(85)90113-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15195449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1985-10-01Epub Date: 2004-04-15DOI: 10.1016/0006-2944(85)90117-6
Gary J. Murray , Thomas W. Doebber , T.Y. Shen , M.S. Wu , M.M. Ponpipom , R.L. Bugianesi , Roscoe O. Brady , John A. Barranger
Human placental β-glucocerebrosidase modified by covalent attachment of N2-{N2,N6-bis[3-(α-d-mannopyranosylthio)propionyl]-l-lysyl}-N6-[3-(α-d-mannopyr-anosylthio) propionyl]-l-lysine was administered to rats by intravenous injection. Comparison of enzyme distribution in isolated liver cell populations indicates an increase in enzyme-specific activity of 18-fold in nonparenchymal cells and only 1.5-fold to hepatocytes compared to uninjected control animals. This macrophage-specific delivery of an active lysosomal enzyme has potential for application in enzyme replacement trials.
{"title":"Targeting of synthetically glycosylated human placental glucocerebrosidase","authors":"Gary J. Murray , Thomas W. Doebber , T.Y. Shen , M.S. Wu , M.M. Ponpipom , R.L. Bugianesi , Roscoe O. Brady , John A. Barranger","doi":"10.1016/0006-2944(85)90117-6","DOIUrl":"10.1016/0006-2944(85)90117-6","url":null,"abstract":"<div><p>Human placental β-glucocerebrosidase modified by covalent attachment of <em>N</em><sup>2</sup>-{<em>N</em><sup>2</sup>,<em>N</em><sup>6</sup>-bis[3-(α-<span>d</span>-mannopyranosylthio)propionyl]-<span>l</span>-lysyl}-<em>N</em><sup>6</sup>-[3-(α-<span>d</span>-mannopyr-anosylthio) propionyl]-<span>l</span>-lysine was administered to rats by intravenous injection. Comparison of enzyme distribution in isolated liver cell populations indicates an increase in enzyme-specific activity of 18-fold in nonparenchymal cells and only 1.5-fold to hepatocytes compared to uninjected control animals. This macrophage-specific delivery of an active lysosomal enzyme has potential for application in enzyme replacement trials.</p></div>","PeriodicalId":8781,"journal":{"name":"Biochemical medicine","volume":"34 2","pages":"Pages 241-246"},"PeriodicalIF":0.0,"publicationDate":"1985-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0006-2944(85)90117-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15195959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1985-10-01Epub Date: 2004-04-15DOI: 10.1016/0006-2944(85)90116-4
D. Kalant, J.C. Crawhall, B.I. Posner
Three different isocratic systems for the separation by reversed-phase high-performance liquid chromatography (HPLC) of different species of insulin have been investigated. The effect of different solvent compositions and temperatures on elution time and resolution have been studied. These studies have been used to devise a method for reversed-phase liquid chromatographic separation of bovine, porcine, and human insulin, as well as the A and B chains of bovine insulin. The method can also be used for the separation of the various products of the iodination of porcine insulin. 125I-A14 tyrosine-labeled porcine insulin can be readily separated from nonlabeled porcine insulin and from other idoinated constitutents of the mixture. A flow-though gamma-counting system that was designed for this work is described.
{"title":"Separation of biological variant insulin molecules from different species by reversed-phase high-performance liquid chromatography (HPLC)","authors":"D. Kalant, J.C. Crawhall, B.I. Posner","doi":"10.1016/0006-2944(85)90116-4","DOIUrl":"10.1016/0006-2944(85)90116-4","url":null,"abstract":"<div><p>Three different isocratic systems for the separation by reversed-phase high-performance liquid chromatography (HPLC) of different species of insulin have been investigated. The effect of different solvent compositions and temperatures on elution time and resolution have been studied. These studies have been used to devise a method for reversed-phase liquid chromatographic separation of bovine, porcine, and human insulin, as well as the A and B chains of bovine insulin. The method can also be used for the separation of the various products of the iodination of porcine insulin. <sup>125</sup>I-A14 tyrosine-labeled porcine insulin can be readily separated from nonlabeled porcine insulin and from other idoinated constitutents of the mixture. A flow-though gamma-counting system that was designed for this work is described.</p></div>","PeriodicalId":8781,"journal":{"name":"Biochemical medicine","volume":"34 2","pages":"Pages 230-240"},"PeriodicalIF":0.0,"publicationDate":"1985-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0006-2944(85)90116-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15023699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1985-08-01Epub Date: 2004-04-15DOI: 10.1016/0006-2944(85)90067-5
K.H. Summer , J. Eisenburg
In five of six patients with symptomatic Wilson's disease (WD) with increased hepatic copper content, increased renal copper excretion, and decreased serum concentrations of ceruloplasmin, significantly low levels of hepatic reduced glutathione (GSH) were found. Three of these patients showed increased levels of oxidized glutathione which in part could account for the missing GSH. These changes may result from increased lipid peroxidation due to the rise of intracellular copper concentration. Furthermore, WD patients showed a 50% decrease in the activity of hepatic GSH S-transferases.
From these results we conclude that the disturbance in the hepatic glutathione system of patients with symptomatic WD may contribute to the perpetuation of liver damage. These patients, additionally, may be predisposed to an increased sensitivity to drugs interacting with glutathione.
在6例伴有肝铜含量增加、肾铜排泄增加、血清铜蓝蛋白浓度降低的症状性威尔逊氏病(WD)患者中,有5例发现肝还原性谷胱甘肽(GSH)水平明显降低。其中三名患者显示氧化谷胱甘肽水平升高,这在一定程度上可以解释谷胱甘肽缺失的原因。这些变化可能是由于细胞内铜浓度升高引起的脂质过氧化作用增加。此外,WD患者肝脏GSH s -转移酶活性降低50%。从这些结果我们得出结论,有症状的WD患者的肝谷胱甘肽系统紊乱可能导致肝损伤的持续存在。此外,这些患者可能对与谷胱甘肽相互作用的药物更敏感。
{"title":"Low content of hepatic reduced glutathione in patients with Wilson's disease","authors":"K.H. Summer , J. Eisenburg","doi":"10.1016/0006-2944(85)90067-5","DOIUrl":"10.1016/0006-2944(85)90067-5","url":null,"abstract":"<div><p>In five of six patients with symptomatic Wilson's disease (WD) with increased hepatic copper content, increased renal copper excretion, and decreased serum concentrations of ceruloplasmin, significantly low levels of hepatic reduced glutathione (GSH) were found. Three of these patients showed increased levels of oxidized glutathione which in part could account for the missing GSH. These changes may result from increased lipid peroxidation due to the rise of intracellular copper concentration. Furthermore, WD patients showed a 50% decrease in the activity of hepatic GSH <em>S</em>-transferases.</p><p>From these results we conclude that the disturbance in the hepatic glutathione system of patients with symptomatic WD may contribute to the perpetuation of liver damage. These patients, additionally, may be predisposed to an increased sensitivity to drugs interacting with glutathione.</p></div>","PeriodicalId":8781,"journal":{"name":"Biochemical medicine","volume":"34 1","pages":"Pages 107-111"},"PeriodicalIF":0.0,"publicationDate":"1985-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0006-2944(85)90067-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15163684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
We measured the activity of aromatic l-amino acid decarboxylase with l-dihydroxyphenylalanine as a substrate (DOPA decarboxylase) in normal lung tissues and lung tumors obtained fresh at surgery. The activity in control human lung tissues was low and variable: 3.50 ± 0.42 pmole/min/mg protein (n = 56, mean ± SE, range 0.01–15), indicating the wide individual variations. Most of small cell carcinoma specimens showed very high activity, as compared with both control lung tissues and with other types of non-SCC lung cancers. Similar results were also obtained in the athymic mice heterotransplants of SCC. High activity was also observed using 5-l-hydroxytryptophan as a substrate (5-HTP decarboxylase) in nine SCC samples. Serotonin was not detected in any control lung tissues, but was detected in all the nine SCC samples, but dopamine was detected only in three out of nine SCC samples.
{"title":"Aromatic l-amino acid decarboxylase activities in human lung tissues: Comparison between normal lung and lung carcinomas","authors":"Toshiharu Nagatsu , Hiroshi Ichinose , Kohichi Kojima , Toru Kameya , Junji Shimase , Tetsuro Kodama , Yukio Shimosato","doi":"10.1016/0006-2944(85)90061-4","DOIUrl":"10.1016/0006-2944(85)90061-4","url":null,"abstract":"<div><p>We measured the activity of aromatic <span>l</span>-amino acid decarboxylase with <span>l</span>-dihydroxyphenylalanine as a substrate (DOPA decarboxylase) in normal lung tissues and lung tumors obtained fresh at surgery. The activity in control human lung tissues was low and variable: 3.50 ± 0.42 pmole/min/mg protein (<em>n</em> = 56, mean ± SE, range 0.01–15), indicating the wide individual variations. Most of small cell carcinoma specimens showed very high activity, as compared with both control lung tissues and with other types of non-SCC lung cancers. Similar results were also obtained in the athymic mice heterotransplants of SCC. High activity was also observed using 5-<span>l</span>-hydroxytryptophan as a substrate (5-HTP decarboxylase) in nine SCC samples. Serotonin was not detected in any control lung tissues, but was detected in all the nine SCC samples, but dopamine was detected only in three out of nine SCC samples.</p></div>","PeriodicalId":8781,"journal":{"name":"Biochemical medicine","volume":"34 1","pages":"Pages 52-59"},"PeriodicalIF":0.0,"publicationDate":"1985-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0006-2944(85)90061-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14129989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Manganese causes a significant rise in hepatic glucokinase and hexokinase in 16-day-old suckling rats, and has an insulinomimetic effect in producing a precocious emergence of glucokinase (EC 2.7.1.2) and a rise in the low Km, kexokinases (EC 2.7.1.1) activities. These enzyme changes occur within 6 hr of manganese administration and there are accompanying increases in plasma insulin and hepatic cyclic GMP. That the effect of manganese is at a site other than, or in addition to, insulin secretion is suggested by the significant increases in glucokinase and hexokinase in 16-day-old streptozotocin-diabetic rats; in this group there is also an increase in hepatic cGMP similar in time scale to that of the normal-manganese-treated group. The effects of manganese and insulin were not additive. It is proposed that one site of action of manganese may be at the level of cyclic GMP systems. The results are also discussed in relation to the known action of manganese at the level of the protein phosphatases.
{"title":"The insulin-mimetic action of Mn2+: Involvement of cyclic nucleotides and insulin in the regulation of hepatic hexokinase and glucokinase","authors":"Samararatne Subasinghe , A.Leslie Greenbaum , Patricia McLean","doi":"10.1016/0006-2944(85)90064-X","DOIUrl":"10.1016/0006-2944(85)90064-X","url":null,"abstract":"<div><p>Manganese causes a significant rise in hepatic glucokinase and hexokinase in 16-day-old suckling rats, and has an insulinomimetic effect in producing a precocious emergence of glucokinase (EC 2.7.1.2) and a rise in the low <em>K</em><sub><em>m</em></sub>, kexokinases (EC 2.7.1.1) activities. These enzyme changes occur within 6 hr of manganese administration and there are accompanying increases in plasma insulin and hepatic cyclic GMP. That the effect of manganese is at a site other than, or in addition to, insulin secretion is suggested by the significant increases in glucokinase and hexokinase in 16-day-old streptozotocin-diabetic rats; in this group there is also an increase in hepatic cGMP similar in time scale to that of the normal-manganese-treated group. The effects of manganese and insulin were not additive. It is proposed that one site of action of manganese may be at the level of cyclic GMP systems. The results are also discussed in relation to the known action of manganese at the level of the protein phosphatases.</p></div>","PeriodicalId":8781,"journal":{"name":"Biochemical medicine","volume":"34 1","pages":"Pages 83-92"},"PeriodicalIF":0.0,"publicationDate":"1985-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0006-2944(85)90064-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14129992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1985-08-01Epub Date: 2004-04-15DOI: 10.1016/0006-2944(85)90063-8
Annette M. Gero, William J. O'Sullivan
Human spleen dihydroorotate dehydrogenase is associated with the mitochondrial membrane and is linked to the respiratory chain via ubiquinone. The enzyme activity was unaffected by pyridine nucleotides. The product of the reaction, orotate, was a potent inhibitor. However, a range of other naturally occurring pyrimidines or purines had no significant effect on the activity. No evidence for the involvement of a complexed metal ion or for an active sulfhydryl group was obtained.
Purification of the enzyme was achieved by preparation of an acetone powder and extraction with Triton X-100, followed by preparative polyacrylamide gel electrophoresis. Activity was observed by the addition of the artificial electron acceptors, ubiquinone 50 or PMS. Purification resulted in alteration of the pH optimum and of other kinetic characteristics. Two molecular-weight species, of molecular weight 88,000 and 98,000, were consistently observed.
The properties of the human spleen enzyme were similar in principle to those for the rat liver enzyme. Differences in the mode of linkage to the respiratory chain for the mitochondrially bound enzyme, and in the characteristics of the purified enzyme, were observed.
{"title":"Human spleen dihydroorotate dehydrogenase: Properties and partial purification","authors":"Annette M. Gero, William J. O'Sullivan","doi":"10.1016/0006-2944(85)90063-8","DOIUrl":"10.1016/0006-2944(85)90063-8","url":null,"abstract":"<div><p>Human spleen dihydroorotate dehydrogenase is associated with the mitochondrial membrane and is linked to the respiratory chain via ubiquinone. The enzyme activity was unaffected by pyridine nucleotides. The product of the reaction, orotate, was a potent inhibitor. However, a range of other naturally occurring pyrimidines or purines had no significant effect on the activity. No evidence for the involvement of a complexed metal ion or for an active sulfhydryl group was obtained.</p><p>Purification of the enzyme was achieved by preparation of an acetone powder and extraction with Triton X-100, followed by preparative polyacrylamide gel electrophoresis. Activity was observed by the addition of the artificial electron acceptors, ubiquinone 50 or PMS. Purification resulted in alteration of the pH optimum and of other kinetic characteristics. Two molecular-weight species, of molecular weight 88,000 and 98,000, were consistently observed.</p><p>The properties of the human spleen enzyme were similar in principle to those for the rat liver enzyme. Differences in the mode of linkage to the respiratory chain for the mitochondrially bound enzyme, and in the characteristics of the purified enzyme, were observed.</p></div>","PeriodicalId":8781,"journal":{"name":"Biochemical medicine","volume":"34 1","pages":"Pages 70-82"},"PeriodicalIF":0.0,"publicationDate":"1985-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0006-2944(85)90063-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"14129991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Glucose incorporated in vitro during nonenzymatic glucosylation into albumin and hemoglobin was fully reducible by sodium borohydride unlike native albumin. Further, a prior hydrolysis under mild conditions (1 m oxalic acid:2 mHCl, 4 hr) was not required for in vitro incorporated glucose to yield maximal color intensity in the phenol-sulfuric acid reaction. Glucosyl-albumin, glucosyl-crystallin, and hemoglobin A1 behaved similarly in this respect. Hexose bound to HbA0 which alone showed an enhanced color intensity on prior acid hydrolysis was also not easily reduced by sodium borohydride. l-Cysteine (0.023 m) enhanced the color yield of glucosyl-hemoglobin, glucosyl-albumin, and glucosyl-crystallin to a lesser extent compared to fructose in the phenol-sulfuric acid reaction. Urea (6 m) also marginally increased the color intensity of glucosyl proteins and fructose.
{"title":"Nature of nonenzymatically bound hexose in hemoglobin, albumin, and crystallin","authors":"Anuradha Kumar, K.Krishna Sharma, T.N. Pattabiraman","doi":"10.1016/0006-2944(85)90068-7","DOIUrl":"10.1016/0006-2944(85)90068-7","url":null,"abstract":"<div><p>Glucose incorporated <em>in vitro</em> during nonenzymatic glucosylation into albumin and hemoglobin was fully reducible by sodium borohydride unlike native albumin. Further, a prior hydrolysis under mild conditions (1 <span>m</span> oxalic acid:2 <span>m</span>HCl, 4 hr) was not required for <em>in vitro</em> incorporated glucose to yield maximal color intensity in the phenol-sulfuric acid reaction. Glucosyl-albumin, glucosyl-crystallin, and hemoglobin A<sub>1</sub> behaved similarly in this respect. Hexose bound to HbA<sub>0</sub> which alone showed an enhanced color intensity on prior acid hydrolysis was also not easily reduced by sodium borohydride. <span>l</span>-Cysteine (0.023 <span>m</span>) enhanced the color yield of glucosyl-hemoglobin, glucosyl-albumin, and glucosyl-crystallin to a lesser extent compared to fructose in the phenol-sulfuric acid reaction. Urea (6 <span>m</span>) also marginally increased the color intensity of glucosyl proteins and fructose.</p></div>","PeriodicalId":8781,"journal":{"name":"Biochemical medicine","volume":"34 1","pages":"Pages 112-119"},"PeriodicalIF":0.0,"publicationDate":"1985-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0006-2944(85)90068-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15163685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 1985-08-01Epub Date: 2004-04-15DOI: 10.1016/0006-2944(85)90060-2
Gordon C. Mills , Frank C. Schmalstieg , Randall M. Goldblum
Studies have been carried out using an XAD-4 resin and ion-exchange chromatography for determination of urinary purines and nucleosides in seven children with severe combined immunodeficiency and in six normal children. These studies have included analyses for five methylated purines or nucleosides produced by catabolism of nucleic acids. The following compounds have been quantitatively determined: 1-methyladenosine, 1-methylinosine, 1-methylguanosine, 1-methylguanine, 3-methylcytidine, adenosine, methylthioadenosine sulfoxide, cytidine, and deoxycytidine. 1-Methyladenosine and 1-methylinosine were most consistently elevated in the urine of immunodeficient children. Methylthioadenosine sulfoxide was very markedly increased in urine of two of the immunodeficient children while more moderate increases were noted with a number of other nucleosides. The germ-free child with severe combined immunodeficiency showed consistently lower excretion levels of these compounds when compared to normal children.
{"title":"Urinary excretion of modified purines and nucleosides in immunodeficient children","authors":"Gordon C. Mills , Frank C. Schmalstieg , Randall M. Goldblum","doi":"10.1016/0006-2944(85)90060-2","DOIUrl":"10.1016/0006-2944(85)90060-2","url":null,"abstract":"<div><p>Studies have been carried out using an XAD-4 resin and ion-exchange chromatography for determination of urinary purines and nucleosides in seven children with severe combined immunodeficiency and in six normal children. These studies have included analyses for five methylated purines or nucleosides produced by catabolism of nucleic acids. The following compounds have been quantitatively determined: 1-methyladenosine, 1-methylinosine, 1-methylguanosine, 1-methylguanine, 3-methylcytidine, adenosine, methylthioadenosine sulfoxide, cytidine, and deoxycytidine. 1-Methyladenosine and 1-methylinosine were most consistently elevated in the urine of immunodeficient children. Methylthioadenosine sulfoxide was very markedly increased in urine of two of the immunodeficient children while more moderate increases were noted with a number of other nucleosides. The germ-free child with severe combined immunodeficiency showed consistently lower excretion levels of these compounds when compared to normal children.</p></div>","PeriodicalId":8781,"journal":{"name":"Biochemical medicine","volume":"34 1","pages":"Pages 37-51"},"PeriodicalIF":0.0,"publicationDate":"1985-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0006-2944(85)90060-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"15163689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}